| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.6 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |